NASDAQ·Healthcare·USD
Henter pris…
Værdiansættelse (TTM)
P/E
18,3
41st %ile · 62pEV/EBITDA
—
P/B
6,8
73rd %ile · 64pP/S
6,3
69th %ile · 70pEV/Sales
7,4
74th %ile · 70pDiv yield
2,5 %
73rd %ile · 39pRegnskabsdata (SEC EDGAR)
Årsregnskab (senest 5 år)
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | |
|---|---|---|---|---|---|
| Omsætning | — | — | — | — | — |
| Bruttoresultat | — | — | — | — | — |
| Nettoresultat | 8.510,0 mio. | 480,0 mio. | 5.665,0 mio. | 4.592,0 mio. | — |
| Op. cash flow | 10.019,0 mio. | 10.828,0 mio. | 8.006,0 mio. | 9.072,0 mio. | — |
| Capex | 563,0 mio. | 523,0 mio. | 585,0 mio. | 728,0 mio. | — |
| Free cash flow | 9.456,0 mio. | 10.305,0 mio. | 7.421,0 mio. | 8.344,0 mio. | — |
| EPS | 6,84 | 0,38 | 4,54 | 3,66 | — |
| Aktiver i alt | 59.023,0 mio. | 58.995,0 mio. | 62.125,0 mio. | 63.171,0 mio. | — |
| Egenkapital | 22.703,0 mio. | 19.330,0 mio. | 22.833,0 mio. | 21.240,0 mio. | — |
| Rentebærende gæld | 27.744,0 mio. | 57.050,0 mio. | 53.570,0 mio. | 55.004,0 mio. | — |
| Aktier udestående | 1.241,0 mio. | 1.246,0 mio. | 1.246,0 mio. | 1.247,0 mio. | — |
Kvartalsregnskab (senest 4 kvartaler)
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|
| Omsætning | — | — | — | — |
| Bruttoresultat | — | — | — | — |
| Nettoresultat | 6.327,0 mio. | 3.275,0 mio. | 1.315,0 mio. | — |
| Op. cash flow | 6.692,0 mio. | 2.584,0 mio. | 1.757,0 mio. | — |
| Capex | 358,0 mio. | 211,0 mio. | 104,0 mio. | — |
| Free cash flow | 6.334,0 mio. | 2.373,0 mio. | 1.653,0 mio. | — |
| EPS | 5,08 | 2,63 | 1,06 | — |
| Aktiver i alt | 58.533,0 mio. | 55.721,0 mio. | 56.434,0 mio. | 58.995,0 mio. |
| Egenkapital | 21.540,0 mio. | 19.674,0 mio. | 19.162,0 mio. | 19.330,0 mio. |
| Rentebærende gæld | 27.747,0 mio. | 27.752,0 mio. | 27.758,0 mio. | 85.575,0 mio. |
| Aktier udestående | 1.242,0 mio. | 1.242,0 mio. | 1.245,0 mio. | 1.246,0 mio. |